[1] |
Gasch AP, Spellman PT, Kao CM, et al. Genomic expression programs in the response of yeast cells to environmental changes[J]. Mol Biol Cell, 2000,11(12):4241⁃4257. doi: 10.1091/mbc.11. 12.4241.
|
[2] |
Liu PC, Thiele DJ. Novel stress⁃responsive genes EMG1 and NOP14 encode conserved, interacting proteins required for 40S ribosome biogenesis[J]. Mol Biol Cell, 2001,12(11):3644⁃3657. doi: 10.1091/mbc.12.11.3644.
|
[3] |
Isaksson HS, Sorbe B, Nilsson TK. Whole genome expression profiling of blood cells in ovarian cancer patients ⁃prognostic impact of the CYP1B1, MTSS1, NCALD, and NOP14[J]. Oncotarget, 2014,5(12):4040⁃4049. doi: 10.18632/oncotarget. 1938.
|
[4] |
Lei JJ, Peng RJ, Kuang BH, et al. NOP14 suppresses breast cancer progression by inhibiting NRIP1/Wnt/β⁃catenin pathway[J]. Oncotarget, 2015,6(28):25701⁃25714. doi: 10.18632/oncotarget.4573.
|
[5] |
Du Y, Liu Z, You L, et al. Pancreatic cancer progression relies upon mutant p53⁃induced oncogenic signaling mediated by NOP14[J]. Cancer Res, 2017,77(10):2661⁃2673. doi: 10.1158/0008⁃5472.CAN⁃16⁃2339.
|
[6] |
Li J, Fang R, Wang J, et al. NOP14 inhibits melanoma proliferation and metastasis by regulating Wnt/β⁃catenin signaling pathway[J]. Braz J Med Biol Res, 2018,52(1):e7952. doi: 10.1590/1414⁃431X20187952.
|
[7] |
李璟蓉, 赵瑞, 方锐华, 等. miR⁃122⁃5p通过靶向NOP14抑制黑素瘤的细胞增殖[J]. 南方医科大学学报, 2018,38(11):1360⁃1365. doi: 10.12122/j.issn.1673⁃4254.2018.11.14.
|
[8] |
Richarz NA, Boada A, Carrascosa JM. Angiogenesis in dermatology ⁃ insights of molecular mechanisms and latest developments[J]. Actas Dermosifiliogr, 2017,108(6):515⁃523. doi: 10.1016/j.ad.2016.12.001.
|
[9] |
匡晓燕. 神经胶质成熟因子-β介导胶质瘤源性血管新生的作用及其机制初探[D]. 重庆: 第三军医大学, 2015.
|
[10] |
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015,65(2):87⁃108. doi: 10.3322/caac. 21262.
|
[11] |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015[J]. CA Cancer J Clin, 2015,65(1):5⁃29. doi: 10.3322/caac.21254.
|
[12] |
Siegel RL, Sahar L, Portier KM, et al. Cancer death rates in US congressional districts[J]. CA Cancer J Clin, 2015,65(5):339⁃344. doi: 10.3322/caac.21292.
|
[13] |
曾红梅, 张思维, 郑荣寿, 等. 2003—2007年中国皮肤黑色素瘤发病与死亡分析 [J]. 中国肿瘤, 2012,21(3):183⁃189. doi: 10.11735/j.issn.1004⁃0242.2012.3.A004.
|
[14] |
Balch CM, Soong SJ. Predicting outcomes in metastatic melanoma[J]. J Clin Oncol, 2008,26(2):168⁃169. doi: 10.1200/JCO.2007. 13.8123.
|
[15] |
Hao M, Zhao G, Du X, et al. Clinical characteristics and prognostic indicators for metastatic melanoma: data from 446 patients in north China[J]. Tumour Biol, 2016,37(8):10339⁃10348. doi: 10.1007/s13277⁃016⁃4914⁃4.
|
[16] |
Petrillo S, Tolosano E, Munaron L, et al. Targeting metabolism to counteract tumor angiogenesis: a review of patent literature[J]. Recent Pat Anticancer Drug Discov, 2018,13(4):422⁃427. doi: 10.2174/1574892813666180528105023.
|
[17] |
Ramjiawan RR, Griffioen AW, Duda DG. Anti⁃angiogenesis for cancer revisited: is there a role for combinations with immunotherapy?[J]. Angiogenesis, 2017,20(2):185⁃204. doi: 10.1007/s10456⁃017⁃9552⁃y.
|
[18] |
Norton KA, Popel AS. Effects of endothelial cell proliferation and migration rates in a computational model of sprouting angiogenesis[J]. Sci Rep, 2016,6:36992. doi: 10.1038/srep36992.
|